store under nitrogen,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cindunistat (free base) 是一种可口服的选择性 iNOS 抑制剂,可用于研究关节炎。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,780 | 现货 | ||
5 mg | ¥ 4,480 | 现货 | ||
10 mg | ¥ 6,380 | 现货 | ||
25 mg | ¥ 9,620 | 现货 | ||
50 mg | ¥ 12,900 | 现货 | ||
100 mg | ¥ 17,500 | 现货 | ||
500 mg | ¥ 34,800 | 现货 |
产品描述 | Cindunistat (free base) is an orally available selective iNOS inhibitor for the study of arthritis. |
体内活性 | In 1457 patients (50 mg/day, n=485; 200 mg/day, n=486; placebo, n=486), 1048 (71.9%) completed the study. 56% had KLG3. In KLG2 patients, JSN after 48 weeks was lower with Cindunistat 50 mg/day versus placebo (p=0.032). Least-squares mean±SE JSN with Cindunistat 50 mg/day ( -0.048±0.028 mm) and 200 mg/day (-0.062±0.028 mm) were 59.9% (95% CI 6.8% to 106.9%) and 48.7% (95% CI -8.4% to 93.9%) of a placebo, improvement was not maintained at 96 weeks. No improvement was observed for KLG3 patients at either time point. Cindunistat did not improve joint pain or function but was generally well tolerated. Cindunistat (50 or 200 mg/day) did not slow the rate of JSN versus placebo. After 48 weeks, KLG2 patients showed less JSN.[1] |
别名 | Cindunistat free base, SD6010, SD-6010 |
分子量 | 219.3 |
分子式 | C8H17N3O2S |
CAS No. | 364067-22-1 |
store under nitrogen,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (250.8 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.56 mL | 22.7998 mL | 45.5996 mL | 113.9991 mL |
5 mM | 0.912 mL | 4.56 mL | 9.1199 mL | 22.7998 mL | |
10 mM | 0.456 mL | 2.28 mL | 4.56 mL | 11.3999 mL | |
20 mM | 0.228 mL | 1.14 mL | 2.28 mL | 5.7 mL | |
50 mM | 0.0912 mL | 0.456 mL | 0.912 mL | 2.28 mL | |
100 mM | 0.0456 mL | 0.228 mL | 0.456 mL | 1.14 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Cindunistat 364067-22-1 Immunology/Inflammation NOS Cindunistat free base SD 6010 SD6010 SD-6010 Inhibitor inhibitor inhibit